Following development by a working group of healthcare professionals from Manchester and Trafford, we now seek comments on the draft document: ‘DOAC switch to edoxaban for NVAF patients – protocol’.
Please note that this consultation will run for 3 weeks; please visit the consultations page to take part. The consultation will run until 5pm on Monday 9th October 2023.
Update 02/10/2023: this consultation is now paused following the updated tariff price for apixaban. Comments will be held, and will not need to be re-submitted if the consultation re-opens.